{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:15:05Z","timestamp":1783433705887,"version":"3.54.6"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To characterize clinical-pathologic tumor features associated with artificial intelligence (AI)\u2013generated risk scores from prior-year screening mammograms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This retrospective study included women who underwent breast biopsy following a screening mammogram in 2021 across four U.S. states. AI risk scores were obtained from prior-year screening mammograms using an FDA-approved AI model. Receiver operating characteristic (ROC) analysis was used to evaluate the discriminative ability of AI risk scores. Among patients with breast cancer, linear regression was used to assess associations between prior-year risk scores and cancer characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 1509 patients included (mean age 58.56\u2009\u00b1\u200912.28 years), 508 (33.7%) had biopsy-confirmed breast cancer. The area under the ROC curve (AUC) for prior-year AI risk score predicting biopsy-confirmed cancer was 0.62 (95% CI: 0.59\u20130.65). In univariate analysis of biopsy-positive patients, invasive lobular carcinoma (ILC) had significantly higher prior-year AI risk scores than ductal carcinoma in situ (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.009), while Grade 3 tumors had significantly lower scores than Grade 1 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.016). After adjusting for tumor grade, the ILC association was no longer significant (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.136), suggesting that tumor grade may mediate this relationship; Grade 3 tumors showed a marginal association with lower risk scores (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.068).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>AI-generated risk scores from prior-year screening mammograms demonstrated modest discrimination between biopsy-confirmed malignant and non-malignant cases and may capture imaging features associated with low-grade tumors. Our findings suggest AI risk scores may reflect subtle imaging patterns of low-grade malignancy 1 year before clinical detection, thereby enhancing our understanding of AI model behavior and informing future research on clinical utility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Question<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>What clinical-pathologic tumor characteristics are reflected in artificial intelligence (AI)-generated risk scores from prior-year screening mammograms among patients with biopsy-confirmed outcomes?<\/jats:italic>\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Findings<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>Prior-year AI risk scores demonstrated modest discrimination between biopsy-confirmed malignant and non-malignant cases and may capture imaging features associated with low-grade tumors.<\/jats:italic>\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Clinical relevance<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>AI-generated risk scores from prior-year screening mammograms may capture subtle imaging features of evolving low-grade malignancy 1 year before clinical detection, offering insights into AI model behavior, enhancing explainability for clinicians, and informing future research on clinical utility.<\/jats:italic>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00330-026-12536-1","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T16:38:33Z","timestamp":1776789513000},"page":"6730-6740","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From pixels to pathology: how artificial intelligence mammographic risk scores capture tumor biology through imaging"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3062-3511","authenticated-orcid":false,"given":"Zi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jafer","family":"Elabeid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thowaiba","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Pantleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelda","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag","family":"Parghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"12536_CR1","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/cac2.12207","volume":"41","author":"S Lei","year":"2021","unstructured":"Lei S, Zheng R, Zhang S et al (2021) Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020. Cancer Commun 41:1183\u20131194","journal-title":"Cancer Commun"},{"key":"12536_CR2","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1001\/jama.2015.12783","volume":"314","author":"KC Oeffinger","year":"2015","unstructured":"Oeffinger KC, Fontham ETH, Etzioni R et al (2015) Breast cancer screening for women at average risk. JAMA 314:1599\u20131614","journal-title":"JAMA"},{"key":"12536_CR3","doi-asserted-by":"publisher","first-page":"e222733","DOI":"10.1148\/radiol.222733","volume":"307","author":"VA Arasu","year":"2023","unstructured":"Arasu VA, Habel LA, Achacoso NS et al (2023) Comparison of mammography AI algorithms with a clinical risk model for 5-year breast cancer risk prediction: an observational study. Radiology 307:e222733. https:\/\/doi.org\/10.1148\/radiol.222733","journal-title":"Radiology"},{"key":"12536_CR4","doi-asserted-by":"publisher","unstructured":"Tendero R, Larroza A, P\u00e9rez-Benito FJ, Perez-Cortes J, Rom\u00e1n M, Llobet R (2025) Breast cancer risk assessment for screening: a hybrid artificial intelligence approach. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-025-11980-9","DOI":"10.1007\/s00330-025-11980-9"},{"key":"12536_CR5","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1093\/jnci\/djac142","volume":"114","author":"CD Lehman","year":"2022","unstructured":"Lehman CD, Mercaldo S, Lamb LR et al (2022) Deep learning vs traditional breast cancer risk models to support risk-based mammography screening. J Natl Cancer Inst 114:1355\u20131363","journal-title":"J Natl Cancer Inst"},{"key":"12536_CR6","doi-asserted-by":"publisher","first-page":"e230989","DOI":"10.1148\/radiol.230989","volume":"309","author":"M Larsen","year":"2023","unstructured":"Larsen M, Olstad CF, Koch HW et al (2023) AI risk score on screening mammograms preceding breast cancer diagnosis. Radiology 309:e230989. https:\/\/doi.org\/10.1148\/radiol.230989","journal-title":"Radiology"},{"key":"12536_CR7","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3390\/diagnostics14121212","volume":"14","author":"EK Park","year":"2024","unstructured":"Park EK, Lee H, Kim M et al (2024) Artificial intelligence-powered imaging biomarker based on mammography for breast cancer risk prediction. Diagnostics (Basel) 14:1212","journal-title":"Diagnostics (Basel)"},{"key":"12536_CR8","doi-asserted-by":"publisher","first-page":"PO4-07-03","DOI":"10.1158\/1538-7445.SABCS23-PO4-07-03","volume":"84","author":"L Leong","year":"2024","unstructured":"Leong L, Xu M, Huang W et al (2024) Abstract PO4-07-03: Machine learning breast cancer risk prediction using sequential past mammograms\u2014a pilot study. Cancer Res 84:PO4-07-03","journal-title":"Cancer Res"},{"key":"12536_CR9","doi-asserted-by":"publisher","first-page":"e222679","DOI":"10.1148\/radiol.222679","volume":"307","author":"C Damiani","year":"2023","unstructured":"Damiani C, Kalliatakis G, Sreenivas M et al (2023) Evaluation of an AI model to assess future breast cancer risk. Radiology 307:e222679. https:\/\/doi.org\/10.1148\/radiol.222679","journal-title":"Radiology"},{"key":"12536_CR10","doi-asserted-by":"publisher","first-page":"eaba4373","DOI":"10.1126\/scitranslmed.aba4373","volume":"13","author":"A Yala","year":"2021","unstructured":"Yala A, Mikhael PG, Strand F et al (2021) Toward robust mammography-based models for breast cancer risk. Sci Transl Med 13:eaba4373. https:\/\/doi.org\/10.1126\/scitranslmed.aba4373","journal-title":"Sci Transl Med"},{"key":"12536_CR11","doi-asserted-by":"publisher","unstructured":"Sacca L, Lobaina D, Burgoa S et al (2024) Promoting artificial intelligence for global breast cancer risk prediction and screening in adult women: a scoping review. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13092525","DOI":"10.3390\/jcm13092525"},{"key":"12536_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1148\/radiol.2020201620","volume":"297","author":"M Eriksson","year":"2020","unstructured":"Eriksson M, Czene K, Strand F et al (2020) Identification of women at high risk of breast cancer who need supplemental screening. Radiology 297:327\u2013333","journal-title":"Radiology"},{"key":"12536_CR13","unstructured":"Pike J, Hoffmeister J (2023) Estimating the likelihood of near-term breast cancer using ProFound AI\u00ae risk theory and clinical performance. Available via https:\/\/www.icadmed.com\/wp-content\/uploads\/2023\/11\/DMM279-Estimating-the-Likelihood-of-Near-Term-Breast-Cancer-White-Paper-Rev1.pdf. Accessed 25 Sep 2025"},{"key":"12536_CR14","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1200\/JCO.22.01564","volume":"41","author":"M Eriksson","year":"2023","unstructured":"Eriksson M, Czene K, Vachon C, Conant E, Hall P (2023) Long-term performance of an image-based short-term risk model for breast cancer. J Clin Oncol 41:2536\u20132545","journal-title":"J Clin Oncol"},{"key":"12536_CR15","unstructured":"(2021) ProFound Detection V4.0. Built for her. Powered for you. Schedule upgrade to ProFound Detection V4. Available via https:\/\/www.icadmed.com\/breast-health\/ai-breast-cancer-detection\/. Accessed 25 Sep 2025"},{"key":"12536_CR16","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1148\/rg.2016150178","volume":"36","author":"AA Rao","year":"2016","unstructured":"Rao AA, Feneis J, Lalonde C, Ojeda-Fournier H (2016) A pictorial review of changes in the BI-RADS fifth edition. Radiographics 36:623\u2013639","journal-title":"Radiographics"},{"key":"12536_CR17","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1200\/JCO.22.02864","volume":"41","author":"AC Wolff","year":"2023","unstructured":"Wolff AC, Somerfield MR, Dowsett M et al (2023) Human epidermal growth factor receptor 2 testing in breast cancer: ASCO\u2013College of American Pathologists guideline update. J Clin Oncol 41:3867\u20133872","journal-title":"J Clin Oncol"},{"key":"12536_CR18","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","volume":"295","author":"LA Carey","year":"2006","unstructured":"Carey LA, Perou CM, Livasy CA et al (2006) Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA 295:2492\u20132502","journal-title":"JAMA"},{"key":"12536_CR19","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/tbj.13738","volume":"26","author":"THC Tay","year":"2020","unstructured":"Tay THC, Ng WY, Ong KW et al (2020) Impact of hormonal status on ductal carcinoma in situ of the breast: outcome and prognostic factors. Breast J 26:937\u2013945","journal-title":"Breast J"},{"key":"12536_CR20","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1200\/JCO.21.01337","volume":"40","author":"A Yala","year":"2021","unstructured":"Yala A, Mikhael PG, Strand F et al (2021) Multi-institutional validation of a mammography-based breast cancer risk model. J Clin Oncol 40:1732\u20131740","journal-title":"J Clin Oncol"},{"key":"12536_CR21","doi-asserted-by":"publisher","first-page":"e232780","DOI":"10.1148\/radiol.232780","volume":"310","author":"J Donnelly","year":"2024","unstructured":"Donnelly J, Moffett L, Barnett AJ et al (2024) AsymMirai: interpretable mammography-based deep learning model for 1-5-year breast cancer risk prediction. Radiology 310:e232780. https:\/\/doi.org\/10.1148\/radiol.232780","journal-title":"Radiology"},{"key":"12536_CR22","doi-asserted-by":"publisher","unstructured":"Hussain S, Ali M, Naseem U et al (2024) Breast cancer risk prediction using machine learning: a systematic review. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2024.1343627","DOI":"10.3389\/fonc.2024.1343627"},{"key":"12536_CR23","doi-asserted-by":"publisher","first-page":"8506","DOI":"10.3390\/ijms25158506","volume":"25","author":"OM Burciu","year":"2024","unstructured":"Burciu OM, Sas I, Popoiu T-A, Merce AG, Moleriu L, Cobec IM (2024) Correlations of imaging and therapy in breast cancer based on molecular patterns: an important issue in the diagnosis of breast cancer. Int J Mol Sci 25:8506","journal-title":"Int J Mol Sci"},{"key":"12536_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2021.110051","volume":"146","author":"F Galati","year":"2022","unstructured":"Galati F, Moffa G, Pediconi F (2022) Breast imaging: beyond the detection. Eur J Radiol 146:110051","journal-title":"Eur J Radiol"},{"key":"12536_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-015-0605-0","volume":"17","author":"K Johnson","year":"2015","unstructured":"Johnson K, Sarma D, Hwang ES (2015) Lobular breast cancer series: imaging. Breast Cancer Res 17:94","journal-title":"Breast Cancer Res"},{"key":"12536_CR26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.5114\/pjr.2021.107426","volume":"86","author":"C Tagliati","year":"2021","unstructured":"Tagliati C, Cerimele F, Di Martino A et al (2021) Invasive lobular carcinoma mammographic findings: correlation with age, breast composition, and tumour size. Pol J Radiol 86:353\u2013358","journal-title":"Pol J Radiol"},{"key":"12536_CR27","doi-asserted-by":"publisher","unstructured":"Fudalej M, Sobiborowicz A, Mormul A et al (2024) The comparison between the two most common histological subtypes of breast cancer\u2014invasive ductal and invasive lobular breast carcinoma. OncoReview. https:\/\/doi.org\/10.24292\/01.OR.141220124","DOI":"10.24292\/01.OR.141220124"},{"key":"12536_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-022-01509-z","volume":"24","author":"A Gastounioti","year":"2022","unstructured":"Gastounioti A, Desai S, Ahluwalia VS, Conant E, Kontos D (2022) Artificial intelligence in mammographic phenotyping of breast cancer risk: a narrative review. Breast Cancer Res 24:14","journal-title":"Breast Cancer Res"},{"key":"12536_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.semcancer.2023.09.001","volume":"96","author":"J Zhang","year":"2023","unstructured":"Zhang J, Wu J, Zhou XS, Shi F, Shen D (2023) Recent advancements in artificial intelligence for breast cancer: image augmentation, segmentation, diagnosis, and prognosis approaches. Semin Cancer Biol 96:11\u201325","journal-title":"Semin Cancer Biol"},{"key":"12536_CR30","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.3390\/cancers14092132","volume":"14","author":"A Petrillo","year":"2022","unstructured":"Petrillo A, Fusco R, Di Bernardo E et al (2022) Prediction of breast cancer histological outcome by radiomics and artificial intelligence analysis in contrast-enhanced mammography. Cancers (Basel) 14:2132","journal-title":"Cancers (Basel)"},{"key":"12536_CR31","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1245\/s10434-013-3155-7","volume":"20","author":"BK Killelea","year":"2013","unstructured":"Killelea BK, Chagpar AB, Bishop J et al (2013) Is there a correlation between breast cancer molecular subtype using receptors as surrogates and mammographic appearance? Ann Surg Oncol 20:3247\u20133253","journal-title":"Ann Surg Oncol"},{"key":"12536_CR32","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.acra.2018.01.023","volume":"26","author":"W Ma","year":"2019","unstructured":"Ma W, Zhao Y, Ji Y et al (2019) Breast cancer molecular subtype prediction by mammographic radiomic features. Acad Radiol 26:196\u2013201","journal-title":"Acad Radiol"},{"key":"12536_CR33","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1002\/jmri.24879","volume":"42","author":"LJ Grimm","year":"2015","unstructured":"Grimm LJ, Zhang J, Mazurowski MA (2015) Computational approach to radiogenomics of breast cancer: luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms. J Magn Reson Imaging 42:902\u2013907","journal-title":"J Magn Reson Imaging"},{"key":"12536_CR34","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1200\/JCO.22.01153","volume":"41","author":"CM Vachon","year":"2023","unstructured":"Vachon CM, Scott CG, Norman AD et al (2023) Impact of artificial intelligence system and volumetric density on risk prediction of interval, screen-detected, and advanced breast cancer. J Clin Oncol 41:3172\u20133183","journal-title":"J Clin Oncol"},{"key":"12536_CR35","doi-asserted-by":"publisher","first-page":"e222575","DOI":"10.1148\/radiol.222575","volume":"306","author":"RJ Acciavatti","year":"2023","unstructured":"Acciavatti RJ, Lee SH, Reig B et al (2023) Beyond breast density: risk measures for breast cancer in multiple imaging modalities. Radiology 306:e222575. https:\/\/doi.org\/10.1148\/radiol.222575","journal-title":"Radiology"},{"key":"12536_CR36","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1158\/2159-8290.CD-22-0373","volume":"12","author":"I Dankwa-Mullan","year":"2022","unstructured":"Dankwa-Mullan I, Weeraratne D (2022) Artificial intelligence and machine learning technologies in cancer care: addressing disparities, bias, and data diversity. Cancer Discov 12:1423\u20131427","journal-title":"Cancer Discov"},{"key":"12536_CR37","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1056\/NEJMra2214964","volume":"389","author":"K Ferryman","year":"2023","unstructured":"Ferryman K, Mackintosh M, Ghassemi M (2023) Considering biased data as informative artifacts in AI-assisted health care. N Engl J Med 389:833\u2013838","journal-title":"N Engl J Med"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-026-12536-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-026-12536-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-026-12536-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:29:38Z","timestamp":1783430978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-026-12536-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["12536"],"URL":"https:\/\/doi.org\/10.1007\/s00330-026-12536-1","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Zi Zhang.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors, Zi Zhang, MD, MSCE, has significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None of the study subjects or cohorts have been previously reported.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}